Journey Medical Corporation
DERM
$6.99
-$0.36-4.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.11% | -13.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.53% | -6.90% | |||
| Cost of Revenue | 114.13% | -57.67% | |||
| Gross Profit | -26.65% | 21.82% | |||
| SG&A Expenses | 5.06% | -11.72% | |||
| Depreciation & Amortization | -68.90% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.59% | -35.02% | |||
| Operating Income | -248.79% | 177.19% | |||
| Income Before Tax | -357.46% | 166.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -367.78% | 163.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -367.78% | 163.64% | |||
| EBIT | -248.79% | 177.19% | |||
| EBITDA | -170.26% | 254.57% | |||
| EPS Basic | -352.24% | 161.34% | |||
| Normalized Basic EPS | -342.67% | 143.36% | |||
| EPS Diluted | -366.81% | 156.25% | |||
| Normalized Diluted EPS | -342.67% | 143.36% | |||
| Average Basic Shares Outstanding | 6.10% | 3.77% | |||
| Average Diluted Shares Outstanding | 6.10% | 3.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||